Baltmedas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 429,062 | 397,130 | 440,430 | 439,684 | 434,896 | 423,926 | 418,375 | 430,008 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -17,671 | -9,849 | 16,516 | 2,953 | 25,919 | 17,213 | 15,072 | 14,522 |
| Equity | 723,233 | 713,384 | 729,900 | 732,853 | 758,772 | 775,985 | 791,057 | 805,579 |
| Liabilities | 124,729 | 122,416 | 100,418 | 81,406 | 67,447 | 51,831 | 63,451 | 58,835 |
| Non-current assets | 372,926 | 356,075 | 339,934 | 324,254 | 308,622 | 292,989 | 299,229 | 284,766 |
| Current assets | 473,199 | 478,024 | 489,426 | 488,518 | 516,168 | 532,826 | 552,515 | 576,730 |
| Total assets | 846,125 | 834,099 | 829,360 | 812,772 | 824,790 | 825,815 | 851,744 | 861,496 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 45,527 | 46,466 | 47,451 |
| Social insurance contributions | - | - | - | - | - | 12,640 | 12,389 | 10,260 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -6.6% | -7.4% | +10.9% | -0.2% | -1.1% | -2.5% | -1.3% | +2.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2.1% | -1.2% | 2.0% | 0.4% | 3.1% | 2.1% | 1.8% | 1.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -2.4% | -1.4% | 2.3% | 0.4% | 3.4% | 2.2% | 1.9% | 1.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -4.1% | -2.5% | 3.7% | 0.7% | 6.0% | 4.1% | 3.6% | 3.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 61,295 | 61,097 | 72,400 | 89,427 | 106,506 | 113,047 | 109,142 | 122,859 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Baltmedas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-05-16 | 2023-05-17 | 81.18 |
Baltmedas - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Baltmedas is: 2 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-28 | 2026-09-02 | 2.0 |
| 2026-08-14 | 2026-08-25 | 2.0 |
| 2026-07-03 | 2026-07-26 | 2.0 |
| 2026-02-21 | 2026-02-21 | 428.0 |
| 2025-05-01 | 2025-05-08 | 0.36 |
| 2025-04-30 | 2025-04-30 | 0.14 |
| 2025-01-10 | 2025-01-15 | 0.4 |
| 2025-01-01 | 2025-01-09 | 0.45 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Baltmedas, UAB (code 261644570) is a Private Limited Liability Company engaged in the wholesale of agricultural machinery, equipment and supplies. In 2025, the company generated revenue of €430.0K and net profit of €14.5K, with a profit margin of 3.4%. Revenue increased by 2.8% year on year, while the 2-year change was +1.4%, indicating a broadly stable top line over the 2023–2025 period. Profitability remained positive but modest, easing from €17.2K in 2023 to €15.1K in 2024 and €14.5K in 2025. Total assets stood at €861.5K at year-end 2025, supported by equity of €805.6K and liabilities of €58.8K. The equity ratio was 93.5% and debt-to-equity 0.07, showing a highly equity-financed balance sheet. Asset turnover was 0.50x, while ROE was 1.8% and ROA 1.7%. With reported revenue per employee of €143.3K and profit per employee of €4.8K, the company showed steady operations and moderate earnings generation in 2025.